Angelini Pharma Hellas S.A, as a member of the Italian Multinational Group, responding to the demands of the era, is rapidly modernised with the aim of becoming fully competitive and responding successfully to the growing demands in both the Greek and European pharmaceutical markets. Since 2008, Angelini Pharma Hellas has begun its business in Greece, following the acquisition of a Greek Pharmaceutical Company, with more than 50 years of experience in the pharmaceutical industry. Since then it has been a member of the Angelini Group Pharmaceutical Group in Europe. The advanced infrastructure and know-how of the Angelini Group allows us to set even higher goals. Angelini Pharma Hellas success in the Greek pharmaceutical market is the deep knowledge of the international markets by the Angelini Group, both in the field of Prescription Drugs and in the OTC (Non-Prescription Drug & Pharmacy Consumer Products). An important role in the development of Angelini Pharma Hellas activities is the long-term cooperation at international as well as at national level. Collaborations through which Angelini Pharma Hellas continually seeks the best solutions to meet the everyday needs of the Greek family, offering Prescription and OTC formulations that cover a wide range of treatment categories. OUR MISSION: We aspire to become a leading European innovator, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies. Our purpose is to make A DIFFERENCE !! OUR VISION: Becoming the natural choice of each family for everyday Health and Well-Being. Continuous growth, through Cooperation, Transparency and Respect to Ethics and Ethical Standards. OUR VALUES: Ethics & Responsibility, Performance, Innovation, Engagement.
| Website | http://www.angelinipharma.gr |
| Revenue | $766.7 million |
| Employees | 28 (21 on RocketReach) |
| Founded | 2008 |
| Address | Achaias & Trizinias St N. Kifissia, Athens, Attica, GR |
| Phone | +30 21 0625 4175 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Healthcare, Drugs, Prescription Drugs, Over The Counter, Biotechnology, Clinical Trials, Drug Development, Medical Devices, Pharmaceutical Manufacturing, Healthcare Solutions, Health, Medicine, Treatment, Therapy, Patient Care, Global Pharma, Multinational Pharma |
| Competitors | Roche, Pfizer, Bayer, Bristol Myers Squibb, Novartis, AbbVie, Johnson & Johnson, Sanofi, GSK, Merck AH +47 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Angelini Pharma Hellas employee's phone or email?
The Angelini Pharma Hellas annual revenue was $766.7 million in 2026.
21 people are employed at Angelini Pharma Hellas.
Angelini Pharma Hellas is based in Athens, Attica.
The NAICS codes for Angelini Pharma Hellas are [32541, 325, 32, 3254].
The SIC codes for Angelini Pharma Hellas are [283, 28].